Current Edition

adult

First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s

Researchers in Japan today announced the launch of a clinical trial to treat Parkinson’s disease with neurological material derived from induced pluripotent stem (iPS) cells, …

Continue Reading →
Bezos

Clinical Trials for CAR T Cells at Bezos Family Immunotherapy Clinic

David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson Research Center, discusses the clinical …

Continue Reading →